SKIN-PREP WIPES BOX 50 01 420400

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 04 report with the FDA on 2012-04-24 for SKIN-PREP WIPES BOX 50 01 420400 manufactured by Smith & Nephew Wound Management.

Event Text Entries

[10169717] There was no product was returned by the customer and so the complaint could not be confirmed. The production records could not be reviewed for this investigation since no lot number was provided. Skin prep wipes is an isopropyl alcohol based liquid film-forming skin preparation that, upon application to intact skin, forms a protective film to help reduce friction during removal of tapes and films. Per the product labeling, it is very important to allow the product to dry thoroughly before any device is applied. The isopropyl alcohol is known irritant. The alcohol content may contribute to drying of the skin. So patients are instructed to avoid trauma to the area and to avoid the use of alcohol and sensitizing agents. Sometimes skin irritation and reactions are expected to occur and severity is marginal with non-serious injury and significant discomfort. An independent medical review of this complaint confirmed that skin prep wipes is not the root cause of the issue. The medical review confirmed that the development of a urinary tract infection is a distinct possibility after an operative procedure, especially in a patient who is catheterized. The medical review confirmed there is no indication in the records whether the patient had a urinary catheter at the time of his orthopedic procedure, what the urinary cultures showed or the antibiotics that were administered. We were unable to determine a specific root cause for this issue; however, we will continue to monitor the complaints system for similar events. Given that product has sufficient warnings and that it has been relocated, no further corrective actions will be taken for this complaint.
Patient Sequence No: 1, Text Type: N, H10


[17098210] In (b)(6) 2011, patient taken by ambulance to hospital. Spent three days in icu diagnosed with urinary sepsis.
Patient Sequence No: 1, Text Type: D, B5


[17183100] In accordance with the provisions of 21cfr803. 50, we are submitting one (1) initial, 30 day report, medwatch fda form 3500a, for a serious and unexpected adverse event which occurred while using no sting skin-prep wipes. Active investigation in progress; awating hippa release of medical information, and sample returns from customer for lab testing. Results of investigation will be submitted in a supplement report.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3006760724-2012-00002
MDR Report Key2546925
Report Source04
Date Received2012-04-24
Date of Report2012-04-24
Date Mfgr Received2012-03-26
Date Added to Maude2012-04-24
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location3
Manufacturer ContactMR TERRY MCMAHON
Manufacturer Street970 LAKE CARILLON DRIVE SUITE 110
Manufacturer CityST. PETERSBURG FL 33716
Manufacturer CountryUS
Manufacturer Postal33716
Manufacturer Phone7273993785
Manufacturer G1SMITH & NEPHEW WOUND MANAGEMENT
Manufacturer Street970 LAKE CARILLON DRIVE SUITE 110
Manufacturer CityST. PETERSBURG FL 33716
Manufacturer CountryUS
Manufacturer Postal Code33716
Single Use0
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameSKIN-PREP WIPES BOX 50 01
Generic NameBANDAGE, LIQUID, SKIN PROTECTANT
Product CodeNEC
Date Received2012-04-24
Model Number420400
Lot NumberUNKNOWN
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSMITH & NEPHEW WOUND MANAGEMENT
Manufacturer Address970 LAKE CARILLON DRIVE SUITE 110 ST. PETERSBURG FL 33716 US 33716


Patients

Patient NumberTreatmentOutcomeDate
10 2012-04-24

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.